Boston Scientific Corporation (BSX)
NYSE · Healthcare
Boston Scientific Corporation Income Statement 2007–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||||
| Revenue | 20.07B | 16.75B | 14.24B | 12.68B | 11.89B | 9.91B | 10.73B | 9.82B | 9.05B | 8.39B | 8.07B | 7.46B | 7.07B | 6.96B | 7.62B | 7.81B | 8.19B | 8.05B | 8.36B |
| Gross Profit | 13.85B | 11.49B | 9.90B | 8.73B | 8.18B | 6.45B | 7.62B | 7.01B | 6.46B | 5.96B | 5.30B | 5.17B | 4.97B | 4.90B | 4.96B | 5.21B | 5.61B | 5.58B | 6.01B |
| Profitability | |||||||||||||||||||
| Operating Income | 3.61B | 2.60B | 2.34B | 1.65B | 1.20B | -80.0M | 1.52B | 1.51B | 1.28B | 447.0M | -283.0M | -301.0M | 120.0M | -3.87B | 904.0M | -656.0M | -894.0M | -1.50B | -14.0M |
| EBITDA | 4.98B | 3.87B | 3.54B | 2.79B | 2.29B | 1.04B | 2.53B | 2.40B | 2.13B | 1.26B | 486.0M | 424.0M | 809.0M | -3.19B | 1.62B | 160.0M | -60.0M | -641.0M | 904.0M |
| Net Income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Per Share Data | |||||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 1,495M | 1,486M | 1,464M | 1,440M | 1,434M | 1,417M | 1,411M | 1,401M | 1,393M | 1,377M | 1,341M | 1,324M | 1,341M | 1,407M | 1,519M | 1,518M | 1,508M | 1,499M | 1,487M |
Boston Scientific Corporation Income Statement — FAQ
Boston Scientific Corporation (BSX) income statement over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BSX's income statement history?
The chart and table above show Boston Scientific Corporation's income statement by year and by quarter, including the growth rate.